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Background: It has been hypothesized that the fact that 
both ribosomal RNA and the group I intron can bind to 
aminoglycoside antibiotics implies that these RNAs are 
evolutionarily related. This hypothesis requires the 
assumption that there are relatively few ways for RNA 
molecules to form aminoglycoside-binding sites. 
Results: We have used in vitro selection to determine the 
diversity of aminoglycoside-binding sites that can 
be formed by RNA molecules. We have generated 
RNA ‘lectins’ that can bind aminoglycosides tightly 
and specifically. Sequence analysis indicates that there 
are many different ways to form tight and specific 
aminoglycoside binding sites. These artificially selected 
binding sites are functionally similar to those that have 
arisen from natural selection. 
Conclusions: Our results suggest that the presence of 
aminoglycoside-binding sites on RNA molecules may not 
be a useful trait for determining evolutionary relatedness. 
Instead, the fact that RNA molecules can bind these ‘low 
molecular-weight effecters’ may indicate that natural prod- 
ucts such as aminoglycosides have evolved to exploit 
sequence- and structure-specific recognition of nucleic acids, 
in much the same way that lexitropsins have been designed 
by chemists to recognise specific nucleic acid sequences. 
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Introduction 
Aminoglycoside antibiotics such as streptomycin or 
kanamycin have long been known to bind to and 
inhibit the function of ribosomal RNA [1,2]. More 
recently, members of this class of compounds have also 
been shown to inhibit the activities of other functional 
RNAs, such as the group I self-splicing intron and the 
hammerhead ribozyme [3-51. These observations have 
prompted speculations that aminoglycoside-binding 
sites on RNAs may be evolutionarily related to one 
another [6]. One popular hypothesis suggests that ‘low 
molecular-weight effecters’ (LMEs) present in the pre- 
biotic milieu were involved in the evolution of the 
earliest RNA molecules by augmenting their structures 
and modulating their functions [7]. These primordial 
LME-binding sites may have persisted into modern 
times, and it is possible that their descendants can still 
be seen in functional RNAs.Although they no longer 
serve their original function, ancient LME-binding sites 
can be identified by virtue of the fact that they con- 
tinue to be exploited by modern LMEs, such as amino- 
glycoside antibiotics. If true, this model would have 
profound implications for how we envision the evolu- 
tion of the RNA world and the origin of the transla- 
tion apparatus. For example, the fact that both rRNA 
and group I introns can bind similar aminoglycoside 
antibiotics has been taken to mean that these molecules 
may have had a common catalytic ancestor [8,9]. 
The alternative possibility is that the aminoglycoside- 
binding sites found in natural RNAs are unrelated to 
one another. This possibility is bolstered by recent 
results from the field of combinatorial chemistry. The 
variety of sequences and structures found in synthetic 
libraries of peptides, nucleic acids, or other compounds 
is equal to or greater than the variety found in nature. 
When such combinatorial libraries have been sieved for 
individual molecules that can bind to target com- 
pounds, the binding species that are recovered fre- 
quently differ from natural binding sites and from one 
another. In particular, nucleic-acid aptamers (binding 
species or sites) that can specifically interact with target 
ligands such as nucleotides, amino acids, vitamins and 
organic dyes have been selected from random-sequence 
RNA pools [lo]. Analysis of the selected molecules has 
revealed that there are often several sequence ‘solutions’ 
to a given ligand-binding ‘problem.’ For example, 
2100 000 different RNAs were found to form specific 
complexes with Cibacron Blue (Kd -100 PM) [l l] . 
Similarly, 100-1000 different RNAs were found to bind 
specifically to tryptophan agarose (Kd -10 PM) [12]. 
The number of different aptamers recovered is gener- 
ally a function of the stringency of the selection. 
However, even in cases where fewer binding species 
with higher affinities were found, multiple sequence 
classes could still be observed. For example, a popula- 
tion of aptamers that bound to ATP (Kd ~50 FM) 1131 
contained at least 13 different sequence classes, and 
aptamers that bound tightly to cyanocobalamin (Kd ~1 
FM) [14] populated at least four divergent sequence 
classes. In contrast, RNAs derived from selections using 
theophylline (Kd ~1 PM) [15] or nicotinamide 
mononucleotide (NMN) (Kd =5 PM) [16] tended to 
fall into single sequence classes. 
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Given these results, the presence of aminoglycoside 
antibiotic binding sites on rRNA, group I introns and 
other RNAs might not indicate that all of these RNAs 
are evolutionarily related, but rather that there are multi- 
ple, distinct ways that RNAs can form ligand-binding 
sites. To distinguish between historical and stochastic 
explanations for the origins of aminoglycoside-binding 
sites, the diversity of possible binding sites must be deter- 
mined. We have used in vitro selection to identify RNA 
sequences that can bind tightly and selectively to two 
different aminoglycoside antibiotics, kanamycin A and 
lividomycin. We find that thousands to millions of differ- 
ent RNA species can bind aminoglycoside antibiotics 
with much the same affinity and selectivity as ribosomal 
RNA or the group I self-splicing intron. 
The selection of antibiotic-binding RNAs from random 
sequence pools also has important implications for drug 
discovery. To our knowledge, this is the first selection of 
RNA ‘lectins’ that can specifically bind to oligosaccha- 
rides. If RNA aptamers can be selected that specifically 
bind to aminoglycosides, then it may also be possible to 
find aptamers that bind to other, similar targets, such as 
the oligosaccharide moieties of glycoproteins or bacterial 
cell wall polysaccharides. 
Results and discussion 
Choice and immobilization of aminoglycoside antibiotics 
The aminoglycosides lividomycin and kanamycin A were 
initially chosen as targets for in vitro selection experi- 
ments (Fig. 1). Both of these drugs are LMEs known to 
bind to ribosomal RNA. These two compounds were 
particularly interesting because they differentially interact 
with the translation apparatus and group I ribozymes; 
both efficiently inhibit translation, but only lividomycin 
affects self-splicing [6]. Th ese compounds are structurally 
as well as functionally dissimilar; lividomycin has two 
additional sugars, and has five amino groups as opposed 
to four for kanamycin A. Thus, this pair of compounds 
can help establish the range of aminoglycosides that can 
elicit binding sites with high affinities and specificities. 
For example, if RNAs can be selected to bind kanamycin 
A, then it is likely that they can be selected to bind other 
members of the ‘kanamycin family’ and members of 
structurally similar families, such as the gentamycins. 
Finally, just as the positively charged amino acid arginine 
proved to be an excellent ligand for polyanionic RNAs, 
the fact that the aminoglycosides contain a number of 
positively charged moieties made them good targets for 
our initial attempts to derive RNA lectins that could 
bind oligosaccharides. 
These aminoglycosides were immobilized via their 
primary or secondary amino groups. Several different affin- 
ity matrices were constructed and tested to determine 
which would give optimal separation characteristics for 
different RNA molecules. Aminoglycosides immobilized 
on A&gel 10 (Biorad, Hercules, CA) and Toyopearl 
(Tosohaas, Montgomeryville, PA) bound a large fraction of 
an unselected random-sequence pool non-specifically, even 
at high salt concentrations (15 M NaCl) or in the presence 
of free ligand (25 r&4). However, epoxy-activated agarose 
(Pierce, Rockford, IL) or Sepharose (Pharmacia, Piscataway, 
NJ) matrices proved to have much lower non-specific 
retention of pool RNAs (suggested by Michael Famulok, 
U. Munich). At a NaCl concentration of 500 mM, less than 
1% of an unselected RNA population bound to these 
a&+ matrices. Such resin-specific effects have previously 
been noted for other ligands, such as ATP [13]. 
In vitro selection of RNA aptamers that bind specifically to 
aminoglycoside antibiotics 
Lividomycin and kanamycin A have molecular weights 
of 762 and 583 Daltons, respectively. Aptamers selected 
to bind other ligands of roughly the same size and func- 
tional complexity have been found to contain core 
binding sequences that are generally 20-30 bases long 
[lo]. Therefore, we chose to employ an RNA pool that 
had a core of 30 random-sequence positions as a starting 
point for our selections (Fig. 2). 
In the first selection cycle (Fig. 2), 15 pg of N30 RNA 
(sequence complexity of 2 x 1013; -15 library equiva- 
lents) was applied to a glycine pre-column to absorb 
species that bound non-specifically to the matrix or 
Lividomycin 
HO 
Kanamycin A 
Fig. 1. Structures of aminoglycoside targets. Lividomycin and 
kanamycin A were immobilized on epoxy-agarose via their 
primary and secondary amines. The target ligand for selection 
was a composite of the agarose backbone, a 12 atom hydrophilic 
spacer arm, a secondary or tertiary amine linkage to the amino- 
glycoside antibiotic, and the aminoglycoside antibiotic itself. 
Interactions between RNA and the column matrix, spacer arm, 
and ligand linkage were minimized by pre-absorbing unselected 
and selected pools to a glycine affinity column made from the 
same activated resin, and by affinity elution, which would have 
favored the isolation of species that could bind the solution 
structure of the l&and. 
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Fig. 2. Schema for selection. Overall view of the steps involved in 
the selection of aminoglycoside-binding sites. The sequences of 
the pool and primers (41.30 and 24.30) used are shown at the 
top. The RNA pool iteratively progressed through pre-column sep- 
arations, affinity column separations and amplification proce- 
dures. In general, only those RNA molecules in the fraction eluted 
with 25 mM antibiotic were amplified and used for further selec- 
tions. However, in round 3 a separate high-salt elution followed 
the affinity elution. The RNAs from this high-salt elution were 
amplified, sieved by affinity chromatography, and the high salt 
fraction was again collected separately. Details of this schema are 
discussed in the text and in Materials and methods. 
spacer arm.The eluate from the pre-column was directly 
loaded onto affinity columns containing either 
lividomycin or kanamycin A. The affinity columns were 
washed with buffer to remove weakly bound RNAs and 
then progressively eluted with 5 mM, 15 mM and 
25 mM solutions of the cognate antibiotic to isolate 
specifically bound RNAs. The tightest-binding species 
from each cycle were amplified by a combination of 
reverse transcription, PCR and ifz vitro transcription. 
Subsequent cycles were similar to the first, except that 
only 10 pg (2 x 1014 sequences; -10 library equivalents) 
of nucleic acid was used. Since ~1% of the applied 
RNA population binds in the first round, and since the 
amplification procedure results in the production of 
40-100 copies of RNA for each cDNA formed, there 
should have been no false selection of RNA species due 
to population ‘bottlenecks’. 
As the RNAs were radiolabeled in each round, the selec- 
tions could be followed by counting the fraction of each 
population that was eluted both specifically and non- 
specifically (Fig. 3).The ability of the populations to bind 
to the antibiotic columns improved in each cycle; by the 
fourth cycle of selection and amplification a majority of 
the RNAs were retained on the columns and could only 
be eluted with free ligand. 
Starting in round 3, we noted that a fraction (20% for 
lividomycin, 5% for kanamycin A) of the RNA popu- 
lation remained on the columns following affinity 
(a) Kanamycin selection 
loo1 
Drain Wash Affinity High-salt 
elution elution 
(b) Lividomycin selection 
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Fig. 3. Iterative selection of aminoglycoside binding sites. (a) 
Kanamycin selection. (b) Lividomycin selection. The column frac- 
tionation of RNAs as a function of selection is shown. 
Radiolabeled RNAs in the initial flow-through, wash, affinity 
elution and high-salt elution steps (cycles 3 and 4 only) were 
quantitated. Radioactive counts from each of the affinity-elution 
steps (5 mM, 15 mM and 25 mM antibiotic) were pooled for the 
purposes of this graph, as were the 5 M NaCl and 4 M CuSCN 
high-salt elution steps. The data for each fraction in each cycle 
were expressed as a percent of the total number of counts eluted. 
Fractions from different rounds are color-coded. For both 
kanamycin A and lividomycin, there is a significant improvement 
in the ability of the RNA population to bind to immobilized and 
soluble aminoglycosides as selection proceeds. 
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Table 1. Relative binding abilities of aminoglycoside-binding aptamers. 
Column fractions (% total)a 
Sample Drain/wash Affinity elutionb High saltC Column resin 
Kanamycin pool 12 78 7.2 2.1 
sla 110 4.4 69 18 8.4 
sla 150 7.6 73 11 8.0 
sla 151 6.6 77 6.6 10 
Sk 21 3.5 73 15 8.8 
sls 26 3.1 79 12 5.9 
sls 254 3.2 79 4.3 14 
Lividomycin pool 25 66 5.2 3.6 
sla 352 74 20 1.5 4.1 
sla 355 4.9 85 3.2 6.9 
Sk 453 47 . 46 3.3 3.3 
sls 457 12 65 15 8.2 
sls 458 8.1 69 15 7.3 
sis 460 13 69 13 5.4 
aRNA was chromatographically partitioned as described in Materials and methods. Values are expressed as a percent of the total 
counts recovered. 
bSum of 5 mM, 15 mM, 20 mM and 25 mM aminoglycoside elutions. 
CSum of 4 M CuSCN, IO mM Tris (pH 8.0) and 5 M NaCl elutions. 
elution.To determine whether these RNAs are from a 
particularly high-affinity class, residual counts were 
eluted with 5 M NaCl and 4 M GuSCN.These ‘high- 
salt’ fractions were amplified and selected separately 
from the affinity-eluted fraction (see Fig. 2). After an 
additional cycle, the high-salt fraction was assayed in 
parallel with the RNA population selected by affinity 
elution. No difference was observed in the amount of 
material that could be affinity eluted (data not shown), 
indicating that this population was similar in composi- 
tion to the population of affinity-eluted RNAs. 
Moreover, individual aptamers from the affinity-eluted 
population have binding characteristics similar to those 
from the population eluted with high salt (Table 1). 
These results were expected, in that the populations 
eluted by high salt could also be removed by further 
affinity elutions (data not shown); thus, the high-salt 
elutions merely facilitated the recovery of tightly 
bound RNAs. 
Selected RNAs comprise a large family of diverse sequences 
and structures 
The total number of aminoglycoside-binding sites in the 
selected population can be roughly estimated by deter- 
mining the fraction of the total sequence diversity that 
was lost at each cycle, a value that has been termed the 
‘selection coefficient’ [ll]. This estimate assumes that 
any given sequence is either completely retained or 
completely eliminated from the population during the 
course of the selection, which is generally not the case. 
It thus provides a lower limit for the total number of 
sequences in a population. In round 1, <O.l% of the 
population was eluted and amplified, while in subse- 
quent rounds ~5% of the population was carried on. 
Using these values, we estimate that there may be up to 
a million different lividomycin- and kanamycin-binding 
sites remaining in the selected population. 
To determine whether the populations were as diverse 
as expected, a spot check of individual sequences was 
carried out. Following round 4, RNAs from both affin- 
ity-eluted and high-salt eluted pools were cloned and 
sequenced. The sequences of lividomycin-binding and 
kanamycin-binding aptamers are shown in Figure 4. 
Inspection of these sets of sequences revealed no dupli- 
cations and no obvious sequence motifs. In addition, a 
multiple sequence alignment was carried out using the 
program CLUSTAL to determine whether there were 
subtle similarities within either of these aptamer sets; 
again, no significant similarities were observed. These 
results were not expected: both the LME hypothesis 
and artificial evolutionary experiments with RNAs that 
interact with the translation apparatus [17] suggest that 
the sequences should have fallen into a relatively small 
number of sequence classes. 
To determine whether aminoglycoside-binding sites 
contained common secondary structural motifs rather 
than common sequence motifs, secondary structural pre- 
dictions were generated using the program MULFOLD. 
Single and multiple stem-loops, internal loops, multi- 
arm junctions and stems with and without bulges are 
found; examples of predicted aptamer structures are 
shown in Figure 5. No predominant secondary structural 
feature appears in the selected RNAs. Further, in differ- 
ent aptamers the flanking constant sequence tracts are 
predicted to participate in different secondary structures. 
Since a particular secondary structure could have been 
most easily formed by using the ‘fixed’ information 
present in the constant sequence tracts, this observation 
confirms that selected sequences are truly dispersed in 
sequence space. As a counter-example, selections for 
arginine-binding RNAs generated identifiable secondary 
structural motifs, but these motifs were found to be 
formed in part from constant-region sequences and thus 
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represented an extremely skewed subset of the original 
random-sequence population [ 18,191. 
Selected sequences bind tightly to their cognate ligands 
The functional as well as structural diversity of amino- 
glycoside binding sites was explored. Binding constants 
for RNA populations and individuals were determined 
using analytical affinity chromatography [ll-14, 181. It 
should be noted that aptamer affinities determined by 
chromatography correspond well with aptamer affinities 
determined by other methods, such as fluorescence 
quenching [16]. RNAs from round 4 were applied to 
their cognate antibiotic affinity columns and the columns 
were washed with 60 column volumes of buffer (as 
opposed to 6 for the selections themselves). Despite this 
extensive wash step, a large fraction of the selected 
RNAs remained bound to the column: >75% of RNAs 
selected to bind to lividomycin and >85% of RNAs 
selected to bind to kanamycin. However, these RNAs 
could be largely eluted by free antibiotic. For example, 
most of the RNAs that bound to the kanamycin column 
could only be eluted by 215 mM concentrations of free 
antibiotic (Fig. 6). The fact that affinity elution is 
required to remove the aminoglycoside-binding 
aptamers indicates that many of the selected sequences 
are interacting specifically with a particular ligand rather 
than non-specifically with a matrix of positive charge. 
Based on these results, the aggregate dissociation constant 
of all complexes between affinity-eluted RNAs and 
kanamycin is estimated to be no more than 220 nM. 
Similar values were obtained for RNAs selected to bind 
to lividomycin. 
The binding characteristics of the selected populations 
were mirrored by individual sequences. Six lividomycin- 
binding and six kanamycin-binding aptamers were pre- 
pared and assayed by analytical affinity chromatography 
(Table 1). Again, aptamers remained bound to immo- 
bilized aminoglycoside antibiotics even after washing 
with 60 column volumes but could be readily eluted 
with free ligand; only a fraction (5-20%) of the applied 
RNA samples were eluted with a further high-salt wash 
or remained bound to the column resin. Individual 
sequences generally bound either slightly more tightly or 
slightly less tightly than the population as a whole. 
Although two of the six lividomycin-binding aptamers 
(sla 352 and sls 453) bound less well to the affinity 
column than the others, affinity elution still proved to be 
effective in removing the bound RNA fraction. 
The aminoglycoside-binding aptamers interact with 
their cognate ligands almost as well as the best aptamers 
observed in other selection experiments. For example, a 
complex between a cyanocobalamin-binding aptamer 
and its ligand has a K, of 88 nM [14], while a complex 
between an aptamer and theophylline has a Kd of 
320 nM [15]. In addition, it is instructive to compare 
RNAs selected to bind organic dyes [ll] with RNAs 
selected to bind aminoglycosides. The organic dyes and 
aminoglycosides are roughly the same size, and contain 
I :a) 
*sta_352 
*sta_355 
sla_361 
sla_362 
sl.a_367 
5 La-372 
5 la-377 
sla_379 
sls_380 
s La-3204 
sta_3205 
sta_3207 
sta_3211 
sta_3214 
sta_3215 
sta_3220 
sta_3227 
sla_3228 
sta_3230 
~1~1-3233 
sla_3234 
sta_3236 
sta_3237 
sla_3238 
sta_3243 
sta_3244 
sta_3248 
*sts_453 
sts_455 
*s1s_457 
*sts_458 
*sts_460 
s15_471 
sls_481 
sts_485 
sts_486 
(b) 
sla_16 
*s1a_110 
*staL150 
*sta_151 
sta_153 
sla_166 
sta_167 
sla_l201 
sta_1202 
sta_1203 
sta_1204 
sla_l210 
sta_1213 
sla_1219 
sta_1220 
sla_1221 
sla_1223 
sta_1224 
sta_1225 
sla_1226 
sla_1227 
sta_1229 
sta_1230 
sla_1231 
sta_1235 
sla_1236 
sta_1239 
sla_1241 
*sts_21 
515-22 
*sls_26 
sts_252 
*sls_254 
sts_258 
sts_259 
sls_261 
sls_262 
sls_266 
~15-268 
A.TCCCCCGTTCCTAGTCTTGTAAGGTAGTA... 
TT.TGGGCATATG.. ATGCAGGGAGCAAACGGG. 
AGACAGTG.GAT..CGCAGGCTACGGGAAATGC. 
AAGTTACTAACCGATGTCAGACCTTGGA.CG.... 
G.GTTGAGGTTGGAGTGCAGGTCTTGGAACC... 
GTAGGGC...AGGACCAGTGGCTTGCTACCAGT. 
GAAAGAGCAGGCCCAAGGTGCGACGTGAAC.... 
CTAAGGTTCGGA..GGTGCGTTTCGATGG..GC. 
A... GCACGCTTGGTGTGCACGATG.GCCCATGG 
.CGAGAGCATGGCGCG.ATATACTGCCGGTA..C 
c.... GGTAGATGG.ACATGGCGGCAAGGCGGTC 
TCACTC.TACGGGTCAGAAGGTGTTCTG.TG..C 
CAAAGGG...AGGGGAAGGGAAAGGCT..TGGTA 
AGTCCCCTAAAGCTGCAATTGGCAGTGCGT.... 
C...CTACAGGCTGTGTGATAGGTA.TGTGCCGC 
TGAGGTCCG... CCAAGTCGGCACCTGTATGCT. 
. . . CTGCTGGGTCAATAGTCTCAGGGGATCGAC. 
CTATGGA....GGCCGATTCAAGGGCAGGTATGT 
GC.CCAGTGCATGAGGGCTTTAGGTG.ACTG..A 
GGGAAAG... GACGCTTGTAGCCGACCAC.GCC. 
ACATCTA...CGTCCCAGGCAGAGGCA...GGGG 
CG.CCGGAAGGATATAAGTGGAGCAC.GAAG..C 
.C.TAGCTGCTAGAGAATCAGAGGTG.GGCG..A 
CAAGATAGTAAA..AGTAAGGCA.GCTGTTTGC. 
TAGTACGCACGTCGCACATGGTTGGCTGTC.... 
C.GCGATGACGATCT.ATTCACATTCGGA.GGG. 
ATTCTCGT.CTGCTATGGGGGGTTCGGAGGG... 
GGACCATGATGAAATGTGCCG.G...AGAATTGA 
G.CCTGTAACCTCTTAAAACTCACAAAGCCGA.. 
ACCTTAGCCCATGCCA.ATAAGTTGGAGGC...C 
.AAGGCGGTTTT..AGGAGGGAT.AAGGTCGTT. 
TCGACTGAGG ATGTACCGTTTTA AGAAGCA 
CC..CACGA.. GGATCCCCAT.GTTAAGTGGAGA 
TGAGCACGACGAGGCCACTAA.GTTCTGTGG... 
. . . CTCGCACGATCCACATGGATTTCCGACG..A 
T.ACCGTCAAA.. GGGAACATTACTAAGACAGG. 
.A..CCGCGGGGT.TGCGGACCGGGAGCTCCAGC 
G... AATTGCCGTAATTTCCCGTGGAGCGAT.GC 
AGATGGACCTATATGGTCATCCCGTGTC...GT. 
AC.TACTCCAGTAGCGTCTAAGTCTGTC....C. 
GGGCCAAAG..TAAAACGGAAGTTC.CGTTATGA 
AGACTA.GCTGATAGATAGGTGCAACG.GTTG.. 
. . _ GTAACAGGTGGGATCTAAGACGCGGTAGA.G 
. . . CAAGTGCG.GTGGCTGAACTACCCGTCGTGA 
TCAGGCTTGT.GT.TGTAAGT..GCACCTTCTCT 
AAAG.TGGG.. AAATCGCGCAA.AAGTGAATATA 
GAGC.CGCATCACCTATAATTGCGTAGAG..G.C 
A.... ACTTGCTGACACCACAAATTGGGGCCCTT 
GAAG.GGCA... GCAACAACAG.GGCTATCGCCA 
GTGACATGTGCAGACAACACAGTATGTGGA.... 
TTGC.CTCACCAC.TACGAGCGAGCCTTC..GTC 
G.GTCGGATATGGGAAGTGCATTCGTAGGA...A 
TTGT.. TGATGG.ACATTGGTGTACCCTGTCGAC 
AAGCATTTATCGC.TGAGAGC..ACCTCGGGAGC 
G..CGCCGAGTCGGTCTACCACTGGTGC...AGG 
CCCGGGATCT.ACCTGCC.CTTAAGCAGTT..GG 
ACGATCGGAA.ACATGCC.GT.AAGCATGT..GT 
.GAT.GGCA.. TGGGAGGGAAC.AAGGGAACTAC 
G.GGGAAG.GTAAGGATCG.TAGACGGGCC...A 
. . . . . AACTTACGGTGGTCGGGATATGGTAGCTG 
G.AACAAGAGTAAGGACGGGCCATCTCATG...G 
* . . GTAGCGGCATATGGTAAATAGGGGGGATGAA 
G.GTGGTTTGCTCCCGTAGTTTTCTACC...ACC 
G.ATTGGCGACTAGGGCTAACTCCCGAGCAC... 
CCCGATGACTTACGCGTA.GAACT.TTGGT..AA 
GGGGGC.ACCGACGAGAA.GTTTGGCTCAA..GG 
T...TTATTTGGTATACTCTCTATGAGTGATTGG 
. * . CTAACTTA.GCAGCTGGGGGTCCTGGATATG 
GTGTGCGTCCAGTTTAAGAACAAGCAGCA..G.. 
ACGCGGCGATGA.GGATTTGT.CACC..ACTGGC 
CGGT.AATA.. TACAAGAGGGG.ATGGGAGGTCG 
. . . TTAG.GGCCGGTGATAGCCTCGGTAGATGAC 
G...TATCGGGTAGG.CTAAGTTGCTAGCACGTG 
.CATCCGCATGCT.TTCGGG..AGCACGCCTGTG 
T..TCAACT.. CAAGCGGGGTGTGCGCGGTTGCA 
Fig. 4. Sequences of aptamers that bind aminoglycoside anti- 
biotics. (a) Aptamers that bind lividomycin. (b) Aptamers that bind 
kanamycin A. Sequence identifiers are shown on the left. * indi- 
cates sequences whose individual binding profiles were deter- 
mined (Tables 1 and 2). ‘Sla’ indicates a species isolated by affinity 
elution; ‘4s’ indicates a species isolated by high salt elution. The 
aptamers have been aligned to maximize similarity using 
CLUSTAL; primers were removed to avoid biasing the alignment. 
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Fig. 5. Structures of aptamers that bind kanamycin. Representative 
structures generated using the program MULFOLD are shown for 
sequences derived from round 4 of the kanamycin A selection. 
Sequences derived from the N30 pool are in black, constant 
region sequences are in red. The proximity of the 5’ and 3’ ends 
of the sequences is a consequence of the preferences of the 
folding program. 
similar numbers of functional groups.The selected RNA 
populations were sieved for similar numbers of cycles. 
However, the aggregate K, for the RNA-dye complexes 
is >lOO PM, nearly 1000 times higher than that for the 
aminoglycoside-RNA complexes.This affinity difference 
can probably be directly attributed to the chemical dif- 
ferences between the two classes of ligands; the reactive 
dyes are all negatively charged, and contain multiple sul- 
fonates, while the aminoglycosides are positively charged, 
and contain multiple amines. This result emphasizes a 
trend found in other selections, that positively charged 
ligands generally elicit tighter-binding aptamers. 
Selected sequences specifically recognize their 
cognate ligands 
Since the target ligands were positively charged, it was 
especially important to determine whether the selected 
RNAs were merely forming non-specific electrostatic 
contacts with any small oligocation or were in fact 
specifically recognizing the shapes and structures of the 
aminoglycoside antibiotics. To determine whether 
selected RNAs could recognize gross structural features 
of their cognate ligands, the RNA populations from 
round 4 were assayed for their ability to bind to cognate 
and non-cognate aminoglycoside affinity columns. 
Aptamers selected to bind to lividomycin bound poorly 
to immobilized kanamycin A, while aptamers selected to 
bind to kanamycin A bound poorly to immobilized 
lividomycin (Fig. 7). 
The binding specificity of selected RNAs was also 
assessed by affinity elution with a series of aminoglyco- 
side antibiotics that were both structurally similar and 
dissimilar to lividomycin (Fig. 8a) and kanamycin A (Fig. 
8b).The values for affinity elution of pool RNAs are the 
result of several independent determinations; clones were 
individually tested and compared with the values 
obtained for the pools (Table 2). In general, antibiotics 
that were structurally similar to the cognate antibiotic 
were more successful affinity eluants than structurally 
dissimilar antibiotics. For example, neomycin and paro- 
momycin are from the same family as lividomycin and, 
overall, were found to be more successful at eluting 
lividomycin-binding RNAs than the less similar com- 
pounds ribostamycin and kanamycin (confirming the 
results of cross-binding studies), and the unrelated drug 
streptomycin (Table 2). Similarly, the kanamycin family 
members dibekacin and amikacin were generally better 
at eluting kanamycin-binding RNAs than the less struc- 
turally similar ribostamycin and the unrelated strepto- 
mycin (Table 2). The abilities of individual aptamers to 
501 
Fig. 6. Elution profile of RNAs bound to the kanamycin affinity 
column. The percent of RNAs that were eluted in each fraction is 
shown. The drain/wash fraction contained 60 column volumes of 
buffer. Six column volumes of 5 mM kanamycin were used for 
the first affinity elution, while three column volumes of antibiotic 
solution were used for each of the remaining affinity elution 
steps. The high-salt elution represents the sum of counts eluted 
with three column volumes of 5 M NaCl and three column 
volumes of 4 M GuSCN. 
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(a) Lividomycin resin 
Drain/Wash 
(b) 
Kanamycin resin 
Drain/Wash Affinity 
elution 
Hi h salt 
B. e utlon 
Fig. 7. Recognition of immobilized aminoglycosides by selected 
pools. (a) Selection on lividomycin resin. (b) Selection on 
kanamycin resin. RNAs from the fourth round of selection were 
applied to both cognate and non-cognate columns; for example, 
both lividomycin- (shaded columns) and kanamycin-binding 
(black columns) populations were applied to a kanamycin column 
(top panel). Following a wash step, the columns were eluted with 
free aminoglycoside antibiotic (kanamycin for kanamycin affinity 
columns, lividomycin for lividomycin affinity columns) and high 
salt. The number of counts in each fraction was normalized to the 
total number of counts eluted. While a fraction of the RNAs from 
both selections remain associated with either cognate and non- 
cognate columns (high-salt elutions), the majority of selected 
RNAs only stick to the column they were selected on and are only 
eluted by the antibiotic they were selected with. 
distinguish between closely related ligand structures may 
provide clues to which epitopes on the aminoglycosides 
are recognized by these aptamers. For example, both the 
kanamycin pool and individual aptamers were surpris- 
ingly good at distinguishing between kanamycin A and 
the closely related kanamycin B (bekanamycin) even 
though these compounds differ by only one amino 
group (at the 2’ position). Individual aptamers may inter- 
act with different epitopes; for example, the kanamycin- 
binding aptamer slall0 recognizes ribostamycin better 
than amikacin, but sla150 has the opposite preference. 
Overall, these results indicate that RNAs selected to bind 
to aminoglycosides do not merely adhere non-specifically 
to agglomerations of positive charges, but can make struc- 
tural distinctions between different positively charged 
ligands.The affinity-elution results cannot be rationalized 
by assuming that the most positively charged ligands elute 
more RNAs; for example, kanamycin B has more amino 
moieties than kanamycin A yet interacts poorly with 
RNA selected to bind to kanamycin A. Streptomycin 
contains two guanidino cations and has been shown to 
bind tightly to the group I intron and ribosomal RNA, 
but it cannot efficiently elute RNAs selected to bind to 
lividomycin or kanamycin A. 
The large family of aminoglycoside-binding aptamers 
appear to interact with their cognate ligands much less 
specifically than aptamers selected to bind other small 
molecules, such as theophylline or ATP [lo]. This may 
be due to the fact that previous in vitro selections have 
focused on repeating the enrichment procedure until 
only those few binding species that have the highest 
affinities and specificities remained. The affinities with 
which the selected populations and aptamers bind to 
their cognate ligands are already comparable to those 
observed in other selection experiments. Since the 
aggregate binding ability of a population has been 
shown to be the average of the binding ability of indi- 
vidual RNAs, highly specific RNAs may still be 
present as a subfraction within our large aminoglyco- 
side-binding populations, and further selection may 
reveal them. We next set out to investigate whether the 
large number of LME sites that we had found by 
artificial selection were functionally similar to natural 
LME sites. 
Comparisons with natural RNAs 
The calculated bounds on the dissociation constants for 
the selected RNA-aminoglycoside complexes compare 
favorably with the interactions observed for natural 
RNA-aminoglycoside complexes. Kanamycin A and 
lividomycin form complexes with individual aptamers 
that on average have K,s of 300 nM or less. In compari- 
son, kanamycin and lividomycin bind to and inhibit 
ribosomal RNA with Kis of 10 p,M or less, while 
lividomycin inhibits the group I intron with a Ki of 
around 1 mM [6,20]. Other aminoglycosides (such as 
neomycin, ribostamycin and tobramycin) also inhibit 
these functional RNAs at concentrations of l-1000 PM. 
It should be noted that the published inhibition and dis- 
sociation constants for complexes between aminoglyco- 
sides and natural RNAs were obtained using buffer 
conditions that differ from one another and from those 
used in our experiments. However, the salt concentration 
used in our selections and assays was uniformly higher 
than those used to derive the previously published 
values. Since the interaction energy between RNAs and 
aminoglycoside antibiotics probably has a large electro- 
static component, aptamers from the selected populations 
should have LME binding sites that are’ on average as 
good as or better than those found on natural RNAs. 
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(b) 
Lividomycin 
(+++) 
Paromycin 
(++I 
Ribostamycin 
(+ ; +I 
Kanamycin A 
(++tl 
Kamamycin B 
(Bekanamycin) 
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Dibekacin 
(++I 
Amikacin 
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Fig. 8. Structures of aminoglycosides. (a) Lividomycin and related aminoglycosides. The panel of aminoglycosides used to elute 
lividomycin-binding RNAs included lividomycin, paromomycin, neomycin B, ribostamycin and streptomycin. Structural differences 
between lividomycin and similar compounds are circled; the mannose residue found in lividomycin but not in paromomycin or 
neomycin B is indicated by [-mannose]. Paromomycin is the aminoglycoside most structurally similar to lividomycin; neomycin B is 
next most similar, then ribostamycin (which lacks two sugar moieties). Streptomycin is from an unrelated family of aminoglycosides 
Symbols below each structure indicate the relative affinity of the lividomycin-binding RNA pool for this structure (see Table 2). For 
ribostamycin and streptomycin two values are shown; the first refers to the lividomycin-binding pool, the second to the kanamycin- 
binding pool. (b) Kanamycin A and related aminoglycosides. The panel of aminoglycosides used to affinity elute kanamycin A-binding 
RNAs included kanamycin B (‘bekanamycin’), dibekacin and amikacin. Ribostamycin and streptomycin were also used (see (a)). 
Structural differences between kanamycin A and similar compounds are circled. Kanamycin B is the aminoglycoside most structurally 
similar to kanamycin A; dibekacin is next most similar, then amikacin. Ribostamycin has a furanose rather than pyranose sugar, which 
is linked 4,5 rather than 4,6. Streptomycin is from an unrelated family of aminoglycosides. Symbols below each structure indicate the 
relative affinity of the kanamycin-binding RNA pool for this structure (seeTable 2). 
The specificity of the selected populations for different 
aminoglycosides also rivals that of natural RNAs. For 
example, footprinting of the group I self-splicing 
intron indicates that neomycin B, episisomicin and 
streptomycin all protect the same subset of bases 
within the ribozyme’s guanosine-binding site [21]. In 
comparison, the selected lividomycin-binding RNAs 
can recognize neomycin B, but have little or no affinity 
for streptomycin. Similarly, the selected kanamycin- 
binding RNAs can recognize structural distinctions 
between antibiotics that are much more closely related 
(Fig. 8b) than those that have been shown bind to the 
group I ribozyme. As another example, hygromycin 
and gentamycin protect the same subset of bases in 
Exherichia coli 16s rRNA from chemical modification 
[2,22], whereas artificially selected RNAs bind differ- 
ently to antibiotics such as kanamycin and dibekacin, 
which are more structurally similar than hygromycin 
and gentamycin. Finally, it has been shown that the 
group I intron can also bind another type of LME, 
arginine, and that ester&cation of arginine has a similar 
effect on RNA binding 1231. We have shown here that 
RNAs selected to bind to aminoglycosides can give 
similar discrimination between sugars with different 
exocyclic moieties. 
The finding that aminoglycoside-binding sites on 
aptamers were functionally similar to LME-binding 
sites on natural RNAs implied that they might be 
structurally similar as well. If true, this would suggest 
that our artificially selected populations might eventu- 
ally converge on a set of sequences or structures similar 
to those generated through natural selection. To deter- 
mine the overlap between artificially and naturally 
selected LME sites, we carried out direct sequence 
comparisons between aptamers and natural LME sites. 
For example, the kanamycin-binding site on rRNA has 
been mapped. Kanamycin binds adjacent to the 3’ ter- 
minal domain of E. coli small subunit rRNA and 
strongly protects residues A,,,,, A,,,, and G,,,, from 
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Table 2. Affinity elution of lividomycin-binding aptamers and kanamycin-binding aptamers by aminoglycosidesa 
Sample Neomycin Paromomycin Ribostamycin Kanamycin Streptomycin 
Lividomycin pool 
sla 352 
sla 355 
SIS 453 
SIS 457 
51s 458 
sls 460 
++ ++ + + - 
+++ ++ +++ + + 
+++ +++ + + _ 
++ ++ + - _ 
++ ++ ++ _ _ 
++ ++ ++ + _ 
++ ++ ++ _ + 
Sample Bekanamycin Dibekacin Amikacin Ribostamycin Streptomycin 
Kanamycin pool + ++ i- + _ 
sla 1 10 _ ++ + ++ _ 
sla 150 - ++ + _ _ 
sla 151 + ++ + + - 
SIS 21 _ ++ ++ ++ - 
sls 26 _ ++ + + - 
sls 254 + +++ + ++ - 
aRadiolabeled RNAs were affinity eluted from their cognate aminoglycoside affinity column by different aminoglycosides.Values are based 
on the sum of 5 mM and 25 mM aminoglycoside elutions and are normalized relative to a control affinity elution with the cognate amino- 
glycoside. Binding values are given as - (<I 0% of bound counts eluted), + (1 l-33% eluted), ++ (34-75% eluted) or +++ (>76% eluted). 
chemical modification [22]. A segment of small subunit 
rRNA sequence involving residues 1390-1500 was 
compared with kanamycin-binding sequences by both 
computer alignment and visual inspection. No stretch 
of residues longer than seven bases was found to be 
similar between this segment of rRNA and any 
aptamer; the longest stretch of similar residues was 
found to lie within secondary structural contexts that 
are predicted to be different in the artificial and natural 
LME sites. Since other natural binding sites for 
kanamycin and lividomycin have not been as carefully 
mapped, we also compared the entire E. coli 16s rRNA 
sequence and the entire Tetvahymena group I intron 
sequence with the aptamer sequences. No significant 
similarities were found. 
Although no similar sites were found on rRNA or ‘the 
group I intron, other natural RNAs might contain 
aminoglycoside-binding sites similar to those in the 
selected population. The probability of finding a given 
aminoglycoside-binding, 30 nucleotide RNA, roughly 
1 in 107, implies that there will generally be a few, but 
not necessarily many (less than loo), such sites in a 
eukaryotic genome. Therefore, we probed the entire 
nucleic acid database (Genbank) with individual 
aptamer sequences. Although natural sequences with 
significant similarity to several of the aptamers were 
identified, none of them were self-splicing introns or 
ribosomal RNAs. 
Assessing the LME hypothesis 
These studies were originally undertaken to determine 
the diversity of LME-binding sites that can be formed 
by RNAs. If only a small number of high-affinity sites 
are possible, then the aminoglycoside-binding sites that 
are found on natural RNAs result from a relatively rare 
event, and so might all arise from one precursor (Fig. 
9a). But if a wide variety of RNA sequences and struc- 
tures bind to aminoglycosides, then the natural binding 
sites found on organismal and viral RNAs might rep- 
resent only a small fraction of the total diversity of 
sites. In this view, the fact that aminoglycoside-binding 
sites are found on both ribosomal RNA and the group 
I intron does not imply that the two molecules have a 
common ancestor (Fig. 9b). 
The fact that numerous, distinct, high-affinity amino- 
glycoside-binding sites can be derived from random 
sequence pools suggests that the model described in 
Figure 9b is more probable than that set out in Figure 
9a. Since many different RNA sequences can fold to 
form many different aminoglycoside-binding sites, the 
mere presence of aminoglycoside-binding sites on 
natural RNAs is probably not indicative of common 
ancestry. The conventional explanation for the presence 
of LME sites on ribosomes would still appear to be the 
most plausible: that the ‘combinatorial chemistry’ pro- 
grams of aminoglycoside-producing microorganisms 
successfully discovered compounds that could bind to 
and inhibit the catalytic core of the ribosome, giving 
them an advantage over their bacterial competitors. 
There are caveats to this analysis. For example, it could 
be argued that it is the probability of finding a given 
aminoglycoside-binding site, rather than the raw number 
of such sites, that makes natural aminoglycoside-binding 
sites a useful character for determining the evolutionary 
relatedness of RNAs. In this case, even though there may 
be millions of different aminoglycoside-binding sites, the 
likelihood of encountering any given one of them in a 
pool of random, 30 nucleotide RNAs by chance is 
roughly 1 in 107. This argument is still not consistent 
300 Chemistry & Biology 1995, Vol 2 No 5 
(4 The ‘LME hypothesis’ (b) The ‘stochastic hypothesis’ 
Small number/probability of 
possible binding sites 
for aminoglycosides 
Large number/probability of 
possible binding sites 
for aminoglycosides 
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Fig. 9. Models for the evolution of 
aminoglycoside binding sites. Amino- 
glycoside binding sites can be observed 
in modern RNAs, and their origins can 
be interpreted in one of several ways. 
Two models are shown. (a) The ‘LME 
hypothesis’ suggests that the function- 
ally similar sites may have a common 
origin. This view is likely to be correct 
if there are only a few, rare ways that 
RNA molecules can form aminoglyco- 
side binding sites. (b) The ‘stochastic 
hypothesis’ is in essence the null 
hypothesis to explain the existence of 
LME sites. In this scenario, RNA mole- 
cules can form aminoglycoside-binding 
sites in many ways, and therefore the 
presence of such binding sites in mod- 
ern RNA molecules (or any set of RNA 
molecules) is to be expected. 
with the notion that there was a primordial catalytic pre- 
cursor to modern ribosomal RNA and group I introns. 
If the original formation of an LME site was a relatively 
improbable event, then the sequence or structural diver- 
gence of this LME site would also have been relatively 
improbable. The lack of sequence or structural similarity 
between selected aptamers suggests that they are distant 
from one another in ‘sequence space’. Thus, they would 
not only be encountered by chance relatively infre- 
quently, but could have mutated from one to the other 
relatively infrequently. Thus, any modern LME sites that 
were derived from a common ancestor should share 
sequence homology. No sequence or structural similarity 
has yet been detected between ribosomal RNA and the 
group I intron, however; they appear to be as different 
from one another as any one of the selected aptamers is 
from them. 
It should also be noted that, although we have selected 
RNA species that bind LMEs, natural RNAs not only 
bind to LMEs but are functionally disrupted by them. It 
therefore remains possible that the LME-binding sites 
of rRNA and the group I intron are more unusual than 
the analysis presented here suggests. For example, many 
LME-binding sites might have been present on a pri- 
mordial ribozyme, but only a few of them might have 
been able to inhibit the function of the ribozyme by a 
mechanism analogous to the allosteric inhibition of 
modern enzymes. An unidentified characteristic of this 
kind might still link aminoglycoside-binding sites on 
rRNA and the group I intron. 
aminoglycosides. Ribosomal RNA and group I introns 
have no obvious similarity at the level of secondary 
structure, and there is no reason to believe that their 
tertiary folds are similar. 
This study cannot definitively show that rRNA and the 
group I intron are not related. However, our results 
show that the fact that they both bind to antibiotics 
does not in itself imply common ancestry. Our observa- 
tion that RNAs that bind to antibiotics are common 
makes the prediction that, if these two RNAs did 
indeed have a common ancestor, they will be found to 
be similar either in their three-dimensional structures or 
in the mechanisms by which they are inhibited by 
antibiotic binding. 
If modern aminoglycosides are not exploiting conserved 
pre-existing LME-binding sites, then they must be 
natural compounds that have evolved the ability to 
recognize RNAs specifically, much as distamycin and 
netropsin can recognize particular DNA sequences. 
Indeed, the ability of aminoglycosides to act as ‘lexi- 
tropsins’ (sequence-reading compounds) by distinguish- 
ing between different RNAs compares favorably with 
the ability of DNA-binding compounds to distinguish 
between different sites on double-stranded DNAs [24]. 
Just as DNA-binding drugs have proven to be useful lead 
compounds for engineering new sequence specificities, 
the aminoglycosides may prove to be similarly interesting 
as starting points for RNA recognition. 
It could also be argued that it may be the three-dimen- 
sional structure of natural LME sites, rather than their 
primary or secondary structural signatures, that has been 
conserved from their common origin. An examination of 
the structures of homologous proteins suggests that ter- 
tiary structure may be more highly conserved than 
primary structure. However, as aminoglycoside-binding 
sites are common in unrelated aptamers, it is likely that 
there are many tertiary structural folds that can bind 
Significance 
The hypothesis that aminoglycoside-binding sites 
on functional RNAs such as rRNA and the 
group I self-splicing intron are historically 
related is predicated on the notion that these 
sites must be relatively unusual. We have selected 
aptamers from a random-sequence pool that can 
bind tightly and specifically to two aminoglyco- 
sides, lividomycin and kanamycin A, and find 
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that there are thousands to millions of distinct 
aminoglycoside binding sites within the pool. 
The artificially evolved aminoglycoside-binding 
sites are functionally similar to aminoglycoside- 
binding sites found on rRNA and the group I 
intron, but bear no obvious sequence or struc- 
tural resemblance to these natural sites. These 
results cast doubt on the hypothesis that the 
aminoglycoside-binding sites of natural RNAs 
share a common evolutionary history. 
Despite their diversity, the selected RNA popula- 
tions bind aminoglycosides as tightly as a 
number of previously selected aptamers that bind 
ligands of similar size and complexity.This result 
emphasizes that oligosaccharides, particularly 
those containing amino sugars, should be excel- 
lent targets for the ilz vitro selection of RNA 
‘lectins’. Moreover, since the Darwinian selection 
of molecules can almost always reduce random- 
sequence populations to a relatively few motifs 
with high aflinities and specificities, the prospect 
now exists that aminoglycoside-binding motifs 
will be extracted that have K, values in the low 
nanomolar range. 
These results emphasize that aminoglycoside 
antibiotics and their derivatives may have 
evolved (and can continue to be used) as natural 
lexitropsins for the sequence- and structure- 
specific recognition of RNAs. Although amino- 
glycosides cannot recognize every sequence, a 
large subset of RNA sequences can be recog- 
nized with high affinity. By examining these 
sequences and structures, it may be possible to 
find new targets for aminoglycosides among 
natural RNAs 
Materials and methods 
Materials 
All aminoglycosides were obtained from Sigma (St. Louis, MO) 
as their sulfate salts. Epoxy-activated affinity resin was obtained 
from Pierce (Rockford, IL). 
Affinity-resin synthesis 
Aminoglycosides (100 p,moles) or glycine (200 pmoles) 
were dissolved in 0.1 M sodium carbonate, pH 10.0 (10 ml), 
mixed with column resin (2.0 g), and allowed to couple for 
16 h at 37” CThe resin was then drained and washed with 3 
column volumes of lx PBS (2.7 mM KCl, 140 mM, NaCl, 
9.9 mM Na2HP0,, 1.8 mM KH,PO,, pH 7.4).The pH of 
the final eluate was 7.4. Residual reactive epoxy residues 
were then blocked with glycine (200 bmoles) in 0.1 M 
sodium carbonate, pH 8.5 for an additional 10 h. The final 
columns were again washed with lx PBS, and column resins 
were stored in lx PBS at 4” C between experiments.To esti- 
mate the approximate concentration of the antibiotic on the 
affinity resin, the number of reactive epoxy groups was 
determined by coupling a chromophore (4-aminopheny- 
lacetic acid or tyrosine) in parallel. For example, the columns 
used for selection were calculated to contain 25 PM 
kanamycin A or lividomycin. All selections were carried out 
using this batch of affinity resin. 
Kanamycin A and lividomycin contain several primary and sec- 
ondary amines and could be tethered to the epoxy-activated 
resin in multiple ways. However, the use of affinity elution for 
the selection step should have negated any effects of column 
ligand heterogeneity, since isolated aptamers would preferentially 
bind the solution conformation of free aminoglycoside. 
Pool synthesis 
The N30 pool (Fig. 2) was constructed using standard methods 
for automated DNA synthesis with nucleoside phosphor- 
amidites. A stochastically random sequence core was obtained 
by mixing the four phosphoramidites in a 3:3:2:2 A:C:G:T 
ratio [25]. Crude pool (5 kg; -1014 sequences) was amplified 
using the polymerase chain reaction (PCR).Twenty-five tubes 
that each contained 0.2 p,g of crude DNA in 200 ~1 of PCR 
reaction mix (50 mM KCl, 10 mM Tris.Cl, pH 8.3, 1.5 mM 
MgCl,, 80 FM each deoxynucleotide triphosphate, 0.4 PM of 
the primers 41.30 and 24.30 (Fig. 2), 2.5 unitsTaq polymerase) 
were carried through five thermal cycles of 94” C, 45 s; 45” C, 
75 s; 72” C, 120 s. Double-stranded DNAs were purified by 
ethanol precipitation in the presence of 1 M ammonium 
acetate, pH 7.4. 
The RNA pool was transcribed from double-stranded DNA 
(1 l_Lg; 2x 1013 sequences) using T7 RNA polymerase in an 
Ampliscribe kit (Epicentre Technologies, Madison, WI). The kit 
was used according to the manufacturer’s directions, except 
that 40 nmoles of OL-~~P UTP (3000 Ci mmol-‘) was added to 
a 20-~1 reaction.The RNA pool was gel-purified on a 10 % 
denaturing polyacrylamide gel as previously described [26]. 
In vitro selection 
For a given cycle of selection, RNA in lx binding buffer 
(500 mM NaCl, 50 mM Tris.Cl, pH 7.6) was heated to 75” C 
for 3 min and allowed to cool to room temperature to equili- 
brate conformers.The RNA solution (15 kg per 100 p,l in 
the first round, 10 kg per 100 ~1 in subsequent rounds) was 
then loaded onto a glycine pre-column (1.0 ml in the first 
round, 0.75 ml in subsequent rounds) that had been pre- 
equilibrated with lx binding buffer. The glycine pre-column 
was washed with 1 column volume of lx binding buffer and 
the sample immediately applied to aminoglycoside affinity 
columns (1.0 ml) that had been pre-equilibrated in lx 
binding buffer. The resin and RNA were mixed for 1 h at 
room temperature. The columnns were developed with 6 
column volumes (6.0 ml) of lx binding buffer, and bound 
RNAs were progressively eluted with 3 volumes each of 5 
mM, 15 mM and 25 mM aminoglycoside in lx binding 
buffer. At this stage, all fractions were counted without scin- 
tillation fluid. Only RNAs from the 25 mM affinity elution 
were ethanol precipitated and used for further selections. To 
remove aminoglycoside antibiotic that precipitated along 
with the nucleic acid, RNAs were resuspended in 100 p,l of 
water and put through a G-50 Sephadex spin column 
(Boehringer, Indianapolis, IN). The flow-through was re- 
precipitated in the presence of glycogen (20 kg). 
Following affinity elution in cycles 3 and 4, the aminoglyco- 
side columns were also eluted with 3 column volumes of 5 M 
NaCl and 3 column volumes of 4 M guanidinium thiocyanate 
(GuSCN) in 10 mM TrisCl, pH 8.0.These high-salt fractions 
were combined, ethanol precipitated, and the RNAs amplified 
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in parallel with those derived from the 25 mM aminoglyco- 
side affinity elution. High-salt-eluted and affinity-eluted 
RNAs from round 3 were separately selected in round 4. 
Two-thirds of the RNA recovered from either high-salt or 
affinity elutions was used to prepare cDNA as previously 
described [27]. One-half of the cDNA (l/3 of the total 
RNA recovered in each cycle) was then amplified using 
PCR. RNAs for a new cycle of selection were prepared by 
in vitro transcription. 
Sequence analysis 
Following the fourth cycle of selection, DNA recovered from 
the PCR amplification reaction was directly cloned into a TA 
cloning vector (InVitrogen, San Diego, CA). Aptamer 
sequences were derived from individual plasmid DNAs using 
standard dideoxy sequencing methods. 
The approximate number of aptamers remaining in the 
selected population was calculated by assuming that the 
percent of RNA that was carried from one cycle to the next 
represented a dilution factor for the complexity of the previ- 
ous population; that is, if 1% of RNAs were selected, then the 
complexity of the population was assumed to decrease by a 
factor of 100 (the ‘selection coefficient’ for that cycle; [ll]). 
As discussed in the text, this estimation is unrealistic because 
it assumes that every species goes to extinction or fixation 
during the selection. However, it should be accurate as a 
lower bound for the total number of species that remain in 
the population. 
Multiple alignments and pairwise sequence comparisons were 
carried out using the MEGALIGN package (DNA*, Madison, 
WI), which includes the CLUSTAL alignment method [27]. 
Secondary structure predictions were made using the program 
MULFOLD [28]. 
Binding assays 
Bounds on values for the dissociation constants of 
RNA-aminoglycoside complexes were determined using a 
modification of the method described by Ellington and 
Szostak [ll]. Since the selected populations bound so tightly 
to their cognate columns, it would have required a prohibitive 
number of buffer washes to remove the majority of the RNA. 
Therefore, upper bounds on the aggregate dissociation con- 
stants were established by demonstrating that a large volume 
of lx binding buffer could not remove RNAs from the 
column, while a small volume of free ligand could. RNAs 
were prepared and applied to affinity columns as described 
above. The columns were developed with up to 60 column 
volumes of lx binding buffer and then RNAs were progres- 
sively eluted with 6 column volumes of 5 mM antibiotic in lx 
binding buffer and 3 column volumes each of 15 mM, 20 mM 
and 25 mM antibiotic in lx binding buffer, followed by high- 
salt washes with 3 column volumes each of 5 M NaCl and 4 
M GuSCN in 10 mM Tris.Cl, pH 8.0.The number of counts 
in each fraction was determined, and the percent of counts in 
each fraction was normalized to the total number of counts 
eluted. Dissociation constants were calculated according to the 
equation [29]: 
Kd = [lGw%~,,, x [(column volume - void volume) + 
(elution volume - void volume)] 
The specificity of binding was determined in two ways. First, 
RNAs selected to bind to one aminoglycoside (for example, 
kanamycin A) were assayed on a column containing the other 
aminoglycoside (for example, lividomycin). This procedure was 
similar to that used for selection, except that only 5 Fg of 
RNA was used and the columns (500 ~1 bed volume) were 
washed with 12 column volumes of lx binding buffer prior to 
affinity and high-salt elution. The number of counts in each 
fraction was determined, and the percentage of counts in each 
fraction was normalized to the total number of counts eluted 
(Fig. 7). Second, RNA populations selected to bind to one 
aminoglycoside were eluted from their cognate column with 
non-cognate aminoglycoside antibiotics. For example, a popu- 
lation of kanamycin-binding RNAs was eluted from a 
kanamycin column with lividomycin. This procedure was 
similar to that used for selection, except that only 0.5 kg of 
RNA was used and the columns (100 ~1 bed volume) were 
developed with only 6 column volumes of lx binding buffer 
and 3 column volumes each of 5 mM and 25 mM aminogly- 
coside antibiotic. The number of counts in each eluted fraction 
was determined and normalized relative to the number of 
counts that had bound to the column (Table 2). 
Acknowledgements: This work was supported by a National 
Science Foundation NationalYoung Investigator Award (A.E.), 
a Scholar Award from The American Foundation for AIDS 
Research (A.E.), and The Pew Scholar Awards in the 
Biomedical Sciences (A.E.). 
References 
1. Rinehart, K.L. Jr. & Shield, L.S. (1980). Aminocvclitol antibiotics: an 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
11. 
12. 
13. 
14. 
15. 
16. 
17. 
18. 
introduction. In Aminocyc/ifo/Antibiotics. (Rinehart, K.L. & Suami, 
T., eds.) ma. l-l 1. American Chemical Societv , Washington D.C. 
Moazed; ‘D. & Noller, H.F. (1987). interactions of antrbiotics with 
functional sites in 16s ribosomal RNA. Nature 327, 389-394. 
von Ahsen, U., Davies, J. & Schroeder, R. (1991). Antibiotic inhibition 
of group I ribozyme function. Nature 353, 368-370. 
von Ahsen, U., Davies, J. & Schroeder, R. (1992). Non-competitive 
inhibition of group I intron RNA self-splicing by aminoglycoside 
antibiotics. /. Mol. Biol. 226, 935-941. 
Stage, T.K., Hertel, K.J. & Uhlenbeck, O.C. (1995). Inhibition of the 
hammerhead ribozyme by neomycin. RNA 1, 95-101 
Davies, J. von Ahsen, U. & Schroeder, R. (1993). Antibiotics and the 
RNA world: a role for low-molecular-weight effecters in biochemi- 
cal evolution? In The RNA World. (Gesteland, R.F. & Atkins, J.F., 
eds), pp. 185-204, Cold Spring Harbor Laboratory Press, New York. 
Davies, J. (1990). What are antibiotics? Archaic functions for 
modern activities. Mol. Microbiol. 4, 1227-1232. 
Noller, H.F. (1991). Drugs and the RNA world, Nature 353, 
302-303. 
Schroeder, R., Streicher, B. & Wank, H. (1993). Splice-site selection 
and decoding: Are they related? Science 260, 1443-I 444. 
Ellinaton, A.D. (1994). Aotamers achieve the desired recornition. 
Curr.“Bioi. 4, 42 7-429. ’ 
Y 
Ellington, A.D. & Szostak, J.W. (1990). In vitro selection of RNA 
molecules that bind specific ligands. Nature 346, 818-822. 
Famulok, M. & Szostak, I.W. (1992). Stereospecific recognition of 
tryptophan agarose by in vitro selected RNA. /. Am. &em. Sot. 
114,3990-3991. 
Sassanfar, M. & Szostak, J.W. (1993) An RNA motif that binds ATP. 
Nature 364, 550-553. 
Lorsch, J.R. & Szostak, J.W. (1994). In vitro selection of RNA 
aptamers specific for cyanocobalamin. Biochemistry 33, 973-982. 
Jenison, R.D., S.C. Gill, A. Pardy & B. Polisky. (1994). High-resolution 
molecular discrimination by RNA. Science263, 1425-1429. 
Lauhon, CT. & Szostak, J.W. (1995). RNA aptamers that bind flavin 
and nicotinamide redox cofactors. /. Am. Gem. Sot. 117, 
1246-1257. 
Ringquist, S. Jones, T., Snyder, E.E., Givson T., Bon;, 1. & Gold, I_. 
(1995). High-affinity RNA ligands to Eschericbia co/i ribosomes and 
ribosomal orotein Sl : comoarison of natural and unnatural binding 
sites. Biochemistry 34, 364b-3648. 
Y 
Connell, G.J., Illannesekare, M. & Yarus, M. (1993). Three small 
oligoribonucleotidei with specific arginine sites. Biochemistry 32, 
In v&w selection of RNA lectins Lato et al. 303 
19. 
20. 
21. 
22. 
23. 
24. 
25. 
5497-5502. 
Connell, C.J. & Yarus, M. (1994). RNAs with dual specificities and 
dual RNAs with similar specificity. Science 264, 1137-l 141. 
Cundliffe, E. (1979). Antibiotics and prokaryotic ribosomes: action, 
interaction, and resistance. In Ribosomes: Structure Function and 
Genetics. pp. 555-581, University Park Press, Baltimore. 
von Ahsen, U. & Noller, H.F. (1993). Footprinting the sites of inter- 
action of antibiotics with catalytic group I intron RNA. Science 260, 
1500-I 503. 
26. 
27. 
28. 
Noller, H.F., Stern, S., Moazed, D., Powers, T., Svensson, P. & 
Changchien, L.-M. (1987) Studies on the architecture and function 
of 16s rRNA, Cold Spring Harbor Symp. Quant. Bid., LII, 695-708. 
Yarus, M. (1988). A specific amino acid binding site composed of 
RNA. Science 240, 1751-I 758. 
Ellington, A.D. (1994b). Using in vitro selection for conventional 
drug design. Drug Devel. Research 33, 102-I 15. 
Bartel, D.P. & Szostak, J.W. (1993). Isolation of new ribozymes from 
29. 
a large pool of random sequences. Science 261, 1411-1418. 
Give’; L., Bartel, D., Zap;, M., Pawul, A., Green, M. & Ellington, 
A.D. (19931. Selective optimization of the Rev-binding element of 
HIV-l. Nucleic Acids Rek. 21, 5509-5516. 
Higgins, D.C. & Sharp, P.M. (1988). CLUSTAL: a package for per- 
forming multiple sequence alignment on a microcomputer. Gene 
73,237-244. 
Jaeger, J.A., Turner, D.H. & Zuker, M. (1989). Predicting optimal and 
suboptimal secondary structure for RNA. Meth. Enrymol. 183, 
281-306. 
Arnold, F.H., Schofield, S.A. & Blanch, H.W. (1986). Analytical affin- 
ity chromatography I. Local equilibrium theory and the measurement 
of association and inhibition constants. /. Chrom. 355, l-12. 
Received: 18 Apr 1995; revisions requested: 2 May 1995; 
revisions received: 3 May 1995. Accepted 5 May 1995. 
